[PDF] Top 20 La tutoría universitaria en el modelo de la convergencia europea
Has 10000 "La tutoría universitaria en el modelo de la convergencia europea" found on our website. Below are the top 20 most common "La tutoría universitaria en el modelo de la convergencia europea".
<p>Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential</p>
... that GLP1 is a better pharmacological target for diabetes therapy than GIP is probably a misconception, as discussed ...of GLP1 and hypersecretion of GIP are the usual pattern of ... See full document
8
<p>Acalabrutinib and Its Therapeutic Potential in the Treatment of Chronic Lymphocytic Leukemia: A Short Review on Emerging Data</p>
... comparative data between acalabrutinib and ibrutinib are available at this time and we caution such ...requiring treatment, and had received at least 1 prior therapy for ...include treatment-emergent ... See full document
22
<p>Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential</p>
... few data are available in older patients with only subgroup analysis and no geriatric data to better character- ize the ...medicine data in that population, to better adapt treatment ... See full document
5
<p>Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data</p>
... obesity, type 2 diabetes mellitus, and dyslipidemia, the preva- lence of NAFLD/NASH has been increasing over the past ...the treatment of NASH, highlighting an important unmet medical ... See full document
18
<p>Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data</p>
... Albiglutide has not been directly compared with either semaglutide or dulaglutide but was assessed versus once- daily liraglutide in the HARMONY 7 trial. 17 Comparison with liraglutide is of interest since this agent was ... See full document
11
Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review
... interesting treatment modality in ...antidiabetes treatment modalities – is low and occurs mainly when incretin mimetics are administered in combination with ...GLP-1 receptor agonists is ... See full document
8
A REVIEW ON THE ROLE OF PPARγ AGONISTS AND HYBRIDS IN TYPE 2 DIABETES AND CARDIOMYOPATHY
... PPAR-γ agonists activate the PPAR-γ and improve the insulin sensitivity, decreases inflammation decreases the plasma levels of free fatty acids (FFA) and also decreases the blood pressure, which in turn inhibits ... See full document
8
<p>Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment</p>
... fi lm is about 1 min, which is the only time available to the drug for penetrating the cornea and accessing the aqueous humor. 45 The next barrier, corneal epithelium, which con- tains multiple desmosomes and tight ... See full document
13
<p>Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis</p>
... available data, selective inhibition of the IL-13 pathway with lebrikizumab appears to be effective for the treatment of moderate-to-severe AD as well, although optimal dosing regimens have yet to be ... See full document
28
<p>Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data</p>
... the short-term recurrence difference observed at 20 months did not persist at any of the later ...than 2% of patients experienced any high grade toxicity (highest ...a potential phase III trial ... See full document
7
<p>Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors</p>
... insulin production, and impaired function, which result in diabetes. 157 However, the impact of oxidative stress can be reduced or modi fi ed by enzymatic antioxidants, including catalase (CAT), ... See full document
15
<p>Profile of Baricitinib and Its Potential in the Treatment of Moderate to Severe Atopic Dermatitis: A Short Review on the Emerging Clinical Evidence</p>
... JAK2. Treatment with baricitinib improved the signs and symptoms of moderate-to-severe AD compared to placebo, but it will be essential to better understand the safety pro fi le of this ... See full document
10
<p>A Systematic Review on Rho-Kinase as a Potential Therapeutic Target for the Treatment of Erectile Dysfunction</p>
... new treatment approach for ED in animal models and clinical studies, published between 2014 and ...2019. Data derived from each study were study design used, interventions applied and main treatment ... See full document
16
Peroxisome Proliferator-Activated Receptors (PPARS): A Target with a Broad Therapeutic Potential for Human Diseases: An Overview
... a dual PPARα/γ agonist with sub- nanomolar potency at PPARγ ...has potential for the treatment of glucose and lipid abnormalities associated with type-2 diabetes and the ... See full document
119
<p>Role of pseudohypoxia in the pathogenesis of type 2 diabetes</p>
... adult-onset diabetes (so called type 2 diabetes) and its complications was fi rst brought up by Williamson et al in 1993 1 and has since garnered increasing attention in the fi eld of ... See full document
7
<p>Khat Chewing and Type 2 Diabetes Mellitus</p>
... To our knowledge, this study is the fi rst study in Saudi Arabia that assessed the prevalence of khat chewing in patients with T2DM and its association with T2DM. Thus, the current study focused on khat chewing as an ... See full document
16
<p>Diabetes-Related Distress and Depression in Saudis with Type 2 Diabetes</p>
... Data entry and analysis were performed using Statistical Package for the Social Sciences software. 16 The data were coded with anonymous identi fi cation numbers in order to guarantee the privacy of the ... See full document
64
<p>Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential</p>
... The potential bene fi t to this group is yet to be demon- strated in studies, but the potential to maintain virological suppression where oral therapy has not would of course be bene fi ...prior ... See full document
21
<p>Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential</p>
... Preliminary data from the dose-ranging Phase II trial, BE ABLE, testing bime- kizumab in plaque psoriasis patients are encouraging as bimekizumab was proven effective and rapid in clearing skin lesions and met the ... See full document
19
<p>A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data</p>
... with diabetes who have an abnormal lipid pro fi le and when combined with persistent hyperglycemia, elevated blood pressure, and an increase in oxidative stress, long-term endothelial damage can ...with ... See full document
11
Related subjects